In force Publication date 06 May 15
Development of ultrasensitive DNA aptamer-based tests for pharmaceutical grade recombinant human growth
Resource description
Project Title: Development of ultrasensitive DNA aptamer-based tests for pharmaceutical grade recombinant human growth hormone
Researcher: Dr. Bruno
Institution: Operational Technologies Corp, USA
Year approved: 2011
Summary: Under this follow on grant proposal, OpTech will develop a new set of discriminatory aptamers against one or more pharmaceutical grade recombinant hGH targets (Genotropin, Norditropin, etc.).